Status: Recruiting
N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma
The purpose of this study is to find out whether N10 chemotherapy is a safe and effective treatment for children with high-risk neuroblastoma.
Participants needed: 45
Trial details
Phase: Phase 2Age: 18-19Biological sex: AllType: InterventionalSponsor: Memorial Sloan Kettering Cancer CenterUpdated: Feb 10, 2026Locations: 1
Eligibility criteria
Diagnosis of NB as defined by histopathology, BM metastases plus high urine cate... [+4]
Severe dysfunction of major organs, i.e., renal, cardiac, hepatic, neurologic, p... [+2]